JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy

Saved in:
Bibliographic Details
Published in:Leukemia Vol. 30; no. 8; pp. 1772 - 1775
Main Authors: Barosi, G, Klersy, C, Villani, L, Bonetti, E, Catarsi, P, Poletto, V, Campanelli, R, Impera, S, Latagliata, R, Viarengo, G, Carolei, A, Massa, M, Musso, M, Crescimanno, A, Gale, R P, Rosti, V
Format: Journal Article
Language:English
Published: England 01-08-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Feature-2
ObjectType-Correspondence-1
ObjectType-Article-3
ISSN:1476-5551
DOI:10.1038/leu.2016.45